BioMark Diagnostics, Inc. (BUX.CX)

0.48 -0.01 (-2.04%) CAD  |  CNSX  |  Jan 19, 16:00
More

BioMark Diagnostics Revenue Estimates for Current Quarter

Revenue Estimates for Current Quarter Chart

View Revenue Estimates for Current Quarter for BUX.CX.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Revenue Estimates for Current Quarter Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Revenue Estimates for Current Quarter Range, Past 5 Years

View Revenue Estimates for Current Quarter Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Revenue Estimates for Current Quarter Benchmarks

View Revenue Estimates for Current Quarter Benchmarks
Start Trial
Justera Health Ltd. --
Neural Therapeutics, Inc. --
ARCpoint, Inc. --
Biocure Technology, Inc. --
Core One Labs, Inc. --